Efficient in vivo pharmacological inhibition of ∆FOSB with YL-0441 in brain
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 38 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 38 samples: 38 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Efficient In Vivo Pharmacological Inhibition of ΔFOSB, an AP-1 Transcription Factor, in the BrainACS chemical neuroscience · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE319820_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1425140 and SRA study SRP677896. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 38 sample titles: 38 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9527104 Sample 43; Control_Male
- GSM9527105 Sample 48; Control_Male
- GSM9527106 Sample 22; Control_Female
- GSM9527107 Sample 24; Control_Female
- GSM9527108 Sample 37; Control_Female
- GSM9527109 Sample 42; Drug_Male
- GSM9527110 Sample 44; Drug_Male
- GSM9527111 Sample 50; Drug_Male
- GSM9527112 Sample 23; Drug_Female
- GSM9527113 Sample 51_Batch2; Drug_Female
- GSM9527114 Sample 43-I; Control_Male
- GSM9527115 Sample 48-I; Control_Male
- GSM9527116 Sample 24-I; Control_Female
- GSM9527117 Sample 37-I; Control_Female
- GSM9527118 Sample 42-I; Drug_Male
- GSM9527119 Sample 44-I; Drug_Male
- GSM9527120 Sample 50-I; Drug_Male
- GSM9527121 Sample 23-I; Drug_Female
- GSM9527122 Sample 41-I; Drug_Female
- GSM9527123 Sample 51-I_Batch2; Drug_Female
- GSM9527124 Sample 12; Control_Male
- GSM9527125 Sample 19; Control_Male
- GSM9527126 Sample 26; Control_Female
- GSM9527127 Sample 51_Batch1; Control_Female
- GSM9527128 Sample 27; Drug_Male
- GSM9527129 Sample 28; Drug_Male
- GSM9527130 Sample 35; Drug_Female
- GSM9527131 Sample 54; Drug_Male
- GSM9527132 Sample 80; Drug_Female
- GSM9527133 Sample 12-I; Control_Male
- GSM9527134 Sample 19-I; Control_Male
- GSM9527135 Sample 26-I; Control_Female
- GSM9527136 Sample 51-I_Batch1; Control_Female
- GSM9527137 Sample 27-I; Drug_Male
- GSM9527138 Sample 28-I; Drug_Male
- GSM9527139 Sample 35-I; Drug_Female
- GSM9527140 Sample 54-I; Drug_Male
- GSM9527141 Sample 80-I; Drug_Female
- GSE318028 Pharmacological inhibition of FKBP51 mitigates early life adversity-induced social deficits 246 samples shares pharmacological, inhibition
- GSE252971 CasRx-Based KRASG12D Silencing for In Vivo Tumor Inhibition in Spontaneous Lung Adenocarcinoma 28 samples shares inhibition, vivo
- GSE302628 Evaluation of the pharmacological effects of oridonin on hepatic ischemia/reperfusion injury in vivo 18 samples shares pharmacological, vivo
- GSE304090 Pharmacological inhibition of the epigenetic enzyme EZH2 attenuates cardiac dysfunction and mitigates lipid metabolism perturbations in a murine model of myocardial infarction 15 samples shares pharmacological, inhibition
- GSE289792 Inhibition of microglial SLC2A5 attenuates brain injury following acute ischemic stroke [RNA-Seq] 12 samples shares inhibition, brain
- GSE325494 Pharmacological inhibition of GLUT1 alleviates fulminant hepatitis by restraining macrophage-induced inflammatory cascades and restoring metabolic homeostasis 9 samples shares pharmacological, inhibition
- GSE266686 Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity [ChIP-Seq] 32 samples shares inhibition
- GSE301496 Transient YAP/TAZ inhibition exposes therapeutic vulnerabilities in advanced cancers [CUT&Run] 20 samples shares inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.